Cargando…
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients
ABSTRACT: HLA-B*57 affects the course of HIV infection. Under antiretroviral therapy, its effects cannot be explained by outstandingly efficient T cell responses alone but may also involve cells of innate immunity. Studying in vitro stimulation with Pam3CSK4, E. coli LPS-B5 and CpG-ODN-2216, we obse...
Autores principales: | Dold, L., Zimmer, L., Schwarze-Zander, C., Boesecke, C., Mohr, R., Wasmuth, J.-C., Ommer, K., Gathof, B., Krämer, B., Nattermann, J., Strassburg, C. P., Rockstroh, J. K., Spengler, U., Langhans, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782382/ https://www.ncbi.nlm.nih.gov/pubmed/33278000 http://dx.doi.org/10.1007/s00109-020-01996-7 |
Ejemplares similares
-
Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019) -
Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)
por: Dold, Leona, et al.
Publicado: (2015) -
Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV
por: Dold, Leona, et al.
Publicado: (2023) -
Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)
por: Dold, Leona, et al.
Publicado: (2017) -
Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis
por: Mohr, Raphael, et al.
Publicado: (2018)